TELA Bio shares are trading lower after the company reported worse-than-expected Q4 sales results. Also, Canaccord Genuity and Lake Street lowered their respective price targets on the stock.

Benzinga Newsdesk www.benzinga.com Negative 96.9%

Neg 96.9% Neu 0% Pos 0%

Comments

No comments yet. Be the first!